You have 9 free searches left this month | for more free features.

Drug Partial Agonism

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Epileptic Seizures Trial in France (MRI)

Completed
  • Epileptic Seizures
  • MRI
  • Marseille, France
  • +3 more
Oct 26, 2022

Drug Resistant Epilepsy Trial in Istanbul (Transcranial Direct Current Stimulation-TessaNova (Teknofil-Turkiye))

Recruiting
  • Drug Resistant Epilepsy
  • Transcranial Direct Current Stimulation-TessaNova (Teknofil-Turkiye)
  • Istanbul, Sarıyer, Turkey
    Koc University
Jul 10, 2023

Melanoma Stage IV, Melanoma Stage III, Immunetherapy Trial (nivolumab)

Not yet recruiting
  • Melanoma Stage IV
  • +3 more
  • (no location specified)
Dec 14, 2022

Cocaine Dependence Trial in New Haven (cocaine HCl, exenatide, )

Completed
  • Cocaine Dependence
  • cocaine hydrochloride
  • +2 more
  • New Haven, Connecticut
    Connecticut Mental Health Center
Feb 25, 2021

Epilepsy, Epilepsy, Temporal Lobe, Partial Epilepsy Trial run by the National Institute of Neurological Disorders and Stroke

Recruiting
  • Epilepsy
  • +2 more
  • Surgical Treatment of drug resistantepilepsy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Epilepsy, Seizures, Focal, Epilepsy Intractable Trial in Moscow (Radiofrequency thermocoagulation)

Enrolling by invitation
  • Epilepsy
  • +3 more
  • Radiofrequency thermocoagulation
  • Moscow, Russian Federation
    Pirogov National Medical and Surgical Center
Feb 18, 2022

Epilepsy, Partial Seizure, Neurostimulator; Complications Trial in United States (RNS System)

Recruiting
  • Epilepsy
  • +4 more
  • RNS System
  • Orange, California
  • +9 more
Aug 3, 2022

Drug-resistant Focal Epilepsy, Epilepsy, Epilepsies, Focal Trial (Laser technology for intracerebral thermocoagulation)

Not yet recruiting
  • Drug-resistant Focal Epilepsy
  • +4 more
  • Laser technology for intracerebral thermocoagulation
  • (no location specified)
Jan 17, 2022

Familial Partial Lipodystrophy Trial in Dallas (Obeticholic Acid, Placebo)

Active, not recruiting
  • Familial Partial Lipodystrophy
  • Obeticholic Acid
  • Placebo
  • Dallas, Texas
  • +1 more
Jan 23, 2022

Muscle Invasive Bladder Cancer, HER2 Expression, Radiotherapy Trial in Shanghai (Disitamab Vedotin and Toripalimab)

Recruiting
  • Muscle Invasive Bladder Cancer
  • +4 more
  • Disitamab Vedotin and Toripalimab
  • Shanghai, Shanghai, China
    Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
Jul 31, 2023

Atlas of Human Cognition by SEEG (MAPCOG-SEEG)

Recruiting
  • Refractory Epilepsy
  • Focal Epilepsy
  • SEEG Group
  • Grenoble, France
  • +3 more
Feb 2, 2023

Epileptic Discharge on Structural Connectivity of Developing

Recruiting
  • Epilepsies, Focal
  • +2 more
  • Electroencephalogram (EEG)
  • +2 more
  • Paris, France
    Fondation Ophtalmologique A. de Rothschild
Jul 26, 2022

Highly Drug-resistant Focal Epilepsy Trial in Worldwide (UCB0942)

Terminated
  • Highly Drug-resistant Focal Epilepsy
  • Brussels, Belgium
  • +14 more
Mar 8, 2022

Focal Epilepsy Trial (Software EstimLT)

Not yet recruiting
  • Focal Epilepsy
  • Software EstimLT
  • (no location specified)
Mar 23, 2022

Focal Drug-resistant Epilepsies

Recruiting
  • Cortical Dysplasia-Focal Epilepsy Syndrome
  • Sequencing of paired blood-brain DNA samples
  • Paris, France
    Fondation Ophtalmologique Adolphe de Rothschld
Feb 1, 2022

Epilepsies, Partial Trial in Ghent (continuous thetaburst stimulation)

Terminated
  • Epilepsies, Partial
  • continuous thetaburst stimulation
  • Ghent, Belgium
    University Hospital Ghent
Jan 31, 2022

Pain Trial in Leiden (Cebranopadol 600 µg, Cebranopadol 800 µg, Cebranopadol 1000 µg)

Recruiting
  • Pain
  • Cebranopadol 600 µg
  • +5 more
  • Leiden, Netherlands
  • +1 more
Aug 4, 2022

Femoral Neck Fractures Trial in Lugano (Dexamethasone is a steroid drug and will be administered as an injectable solution

Recruiting
  • Femoral Neck Fractures
  • Dexamethasone is a steroid drug and will be administered as an injectable solution (4mg/ml)
  • Lugano, Switzerland
    Christian Candrian
Mar 22, 2022

Epilepsy in Children, Focal Epilepsy, Epilepsy Intractable Trial in London (Combined Micro-Macro SEEG Electrodes)

Active, not recruiting
  • Epilepsy in Children
  • +6 more
  • Combined Micro-Macro SEEG Electrodes
  • London, United Kingdom
    Great Ormond Street Hospital NHS Foundation Trust
Nov 18, 2021

Immune Mediated Inflammatory Diseases Trial in Leiden (BAY1834845, BAY1830839, Prednisolone)

Completed
  • Immune Mediated Inflammatory Diseases
  • Leiden, Netherlands
    Center for Human Drug Research
Dec 15, 2022

Pharmacodynamic Trial in Salt Lake City (Nalmefene HCl, Naloxone HCl)

Completed
  • Pharmacodynamic
  • Nalmefene hydrochloride
  • Naloxone hydrochloride
  • Salt Lake City, Utah
    PRA Health Sciences
Dec 8, 2022

Drug Use Investigation Of Gabapentin

Completed
  • Epilepsies, Partial
  • (no location specified)
Feb 1, 2021

Epilepsy, Unspecified, Refractory (Medically) Trial in United States (MRgFUS Ablation of Epileptic Foci)

Recruiting
  • Epilepsy
  • Neuro Ablation - Functional
  • Stanford, California
  • +3 more
Sep 7, 2022

Epilepsies, Partial, Epilepsy Intractable Trial in Bosisio Parini (Standard of care, Functional magnetic resonance

Recruiting
  • Epilepsies, Partial
  • Epilepsy Intractable
  • Standard of care
  • +2 more
  • Bosisio Parini, Lecco, Italy
    Sara Minghetti
Aug 18, 2021

Bioequivalence Trial in Cairo (Test product (T) 40 mg Hard Gelatin Capsules, Reference product (R) 40 mg Hard Gelatin Capsules)

Completed
  • Bioequivalence
  • Test product (T) 40 mg Hard Gelatin Capsules
  • Reference product (R) 40 mg Hard Gelatin Capsules
  • Cairo, Egypt
    Future Research Center (FRC)
Feb 10, 2022